Amsterdam UMC Stichting — Sponsor Intelligence | 99 EU Trials

Filter these 99 trials by condition, phase, country and more.

Open in Search →

99 Registered trials

56 Recruiting

23 Completed trials

10 Countries active

125 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 18 Phase II/III: 4 Phase II: 24 Phase I/II: 9 Phase III/IV: 6 Phase IV: 35 Phase I (Other): 2 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

23 of 23 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Fibrodysplasia ossificans progressiva 2 Colitis ulcerative 2 Crohn's disease 1 Heritable pulmonary arterial hypertension 1 Menopause 1 Pitt-Hopkins syndrome 1 Psoriasis 1 Vulval cancer stage I 1 Adrenocortical carcinoma 1 Bush-Francis catatonia rating scale 1 Complicated appendicitis 1 Lupus nephritis 1

Top IMPs

IPILIMUMAB 3 [18F]FLUORO-PEG-FOLATE 2 CAPECITABINE 2 DURVALUMAB 2 ESTRADIOL 2 FLORTAUCIPIR (18F) 2 FLUDEOXYGLUCOSE (18F) 2 HYDROCORTISONE 2 METHOTREXATE 2 PEMBROLIZUMAB 2 PROGESTERONE, MICRONISED 2 SODIUM CHLORIDE 2

All trials

99 total

The Effect of Mitapivat on Cerebral Perfusion and Oxygen Metabolism in Sickle Cell Disease Pending

2024-513528-41-02 Phase III 1 country MITAPIVAT
GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY) Pending

2024-514743-28-00 Phase II 1 country
Changes in the tumour microenvironment after intravenous or intradermal administration of anti-CTLA-4 in combination with anti-PD1 treatment… Pending

2024-516545-39-01 Phase I/II 1 country IPILIMUMAB
Head-to-head comparison of six different botox products voor glabellar frown wrinkles. Pending

2024-516865-35-01 Phase IV 1 country BOTULINUM TOXIN TYPE A; BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX; CLOSTRI…
ATLAS trial Pending

2024-517233-40-00 Phase IV 1 country CIPROFLOXACIN; METRONIDAZOLE
Colchicine to inhibit atherosclerosis in patients with cancer receiving immune therapy Pending

2024-518100-45-00 Phase III 1 country
Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY) Pending

2024-519737-30-00 Phase IV 1 country ANDEXANET ALFA; CHARCOAL, ACTIVATED; HUMAN COAGULATION FACTOR IX, PROTEIN C, HUM…
Research on two creams (Monobenzon / Imiquimod) together with the standard treatment for advanced or metastatic melanoma (ImMI). Pending

2024-520052-19-04 Phase I/II 1 country
Clinical Application of the Androgen Receptor Inhibitor Darolutamide to Upregulate the Prostate-Specific Membrane Antigen (PSMA) Protein Exp… Pending

2025-520482-52-03 Phase I/II 1 country DAROLUTAMIDE
SPatial Heterogeneity of INtratumoral drug distribution Pending

2025-520530-32-00 Phase IV 1 country ANASTROZOLE; LETROZOLE; RIBOCICLIB
Effectiveness of CBD on behavioural problems in patients with TSC, FXS and Sanfilippo Pending

2025-520846-31-00 Phase III 1 country CANNABIDIOL
Locating microclots with PET in post-COVID syndrome Pending

2025-522348-42-00 Phase I/II 1 country
Post-INFECT: Investigating Neuroinflammation and its effects in post-COVID syndrome Pending

2025-522349-23-00 Phase III 1 country FLUDEOXYGLUCOSE (18F)
Test-Retest Evaluation of [18F]F-AraG in Lung Tumors (TREAT) Pending

2025-522404-24-01 Phase II/III 1 country
Pain Relief via Mouthwash or Intravenous Infusion in Mouth Inflammation after Chemotherapy Pending

2025-522545-22-00 Phase II 1 country ESKETAMINE; ESKETAMINE HYDROCHLORIDE
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases Pending

2025-522834-30-01 Phase II 1 country (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHY…
SHIELD – Swift Hydrocortisone Intervention after trauma exposure Pending

2025-523350-13-02 Phase II 1 country HYDROCORTISONE
Methotrexate in paediatric and adolescent Crohn’s disease: an observational study Pending

2025-524129-42-00 Phase IV 1 country METHOTREXATE
A randomized, placebo-controlled trial to assess the efficacy, tolerability, and pharmacokinetics of clemastine in children and adults with … Pending

2025-524195-29-00 Phase II 1 country CLEMASTINE FUMARATE
MERCURE study: MEthotrexate in ReCurrent dVIN Pending

2025-524373-17-00 Phase IV 1 country METHOTREXATE
Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial Recruiting

2025-522128-28-00 Phase I (Other) 1 country
TADalafil in early-stage Parkinson’s Disease (TAD-PD) Recruiting

2025-521819-39-00 Phase II 1 country
NON-IV: Neo-adjuvant peritumOral immuNotherapy In Vulvar cancer Recruiting

2025-520712-34-00 Phase I (Other) 1 country
RECOMPENSE: Right vEntricular COMPENsation with SotatercEpt. A prospective single arm open label phase IV study to evaluate the effects of s… Recruiting

2024-512543-23-00 Phase IV 1 country SOTATERCEPT

Showing 1–24 of 99 trials

← All sponsors A–Z